We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.91B
AUM Growth
-$77.2M
Cap. Flow
-$132M
Cap. Flow %
-6.91%
Top 10 Hldgs %
21.78%
Holding
502
New
175
Increased
58
Reduced
71
Closed
186

Top Buys

Rank Stock Value
1
DELL icon
Dell
DELL
+$58.2M
2
AABA
Altaba Inc
AABA
+$34.2M
3
KNX icon
Knight Transportation
KNX
+$23.4M
4
BIG
Big Lots, Inc.
BIG
+$20.4M
5
PCG icon
PG&E
PCG
+$16.4M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$29.1M
2
BGS icon
B&G Foods
BGS
+$27.4M
3
CPRI icon
Capri Holdings
CPRI
+$27.3M
4
CYBR
CyberArk
CYBR
+$26.8M
5
SKX
Skechers
SKX
+$23.9M

Sector Composition

Rank Sector Weight
1 Technology 12.24%
2 Industrials 9.75%
3 Consumer Discretionary 7.15%
4 Communication Services 4.92%
5 Healthcare 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCS
301
DELISTED
OncoSec Medical Incorporated
ONCS
$163K 0.01%
+455
New +$159K
EGIO
302
DELISTED
Edgio, Inc. Common Stock
EGIO
$161K 0.01%
+913
New +$180K
VXX
303
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$140K 0.01%
+5,010
New +$165K
AXDX
304
DELISTED
Accelerate Diagnostics
AXDX
$99K 0.01%
+378
New +$88.6K
RIGL icon
305
CALL
Rigel Pharmaceuticals
RIGL
$692M
$77K ﹤0.01%
+1,990
New +$75.7K
GCVRZ
306
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$76K ﹤0.01%
+200,000
New +$75.9K
ADYX
307
DELISTED
Adynxx Inc
ADYX
$68K ﹤0.01%
6,250
-1,250
-17% -$19.4K
EVOK
308
DELISTED
Evoke Pharma
EVOK
$57K ﹤0.01%
+174
New +$72.1K
NPTN
309
DELISTED
NEOPHOTONICS CORP
NPTN
$56K ﹤0.01%
8,580
-526,520
-98% -$3.22M
HAPN
310
Happen Inc
HAPN
$2.16B
$54K ﹤0.01%
2,634
-187,365
-99% -$4.66M
MRNS
311
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$53K ﹤0.01%
1,632
-11,868
-88% -$320K
VEACW
312
DELISTED
Vantage Energy Acquisition Corp.
VEACW
$40K ﹤0.01%
+35,000
New +$42.8K
EGLT
313
DELISTED
Egalet Corporation
EGLT
$33K ﹤0.01%
100,000
X
314
DELISTED
US Steel
X
$6K ﹤0.01%
158
-17,500
-99% -$509K
DE icon
315
Deere & Co
DE
$169B
$2K ﹤0.01%
+11
New +$1.54K
CAT icon
316
Caterpillar
CAT
$402B
$1K ﹤0.01%
+9
New +$1.25K
AAL icon
317
American Airlines Group
AAL
$9.9B
-317,620
Closed -$15.1M
AAPL icon
318
CALL
Apple
AAPL
$4.95T
-40,000
Closed -$1.54M
AAPL icon
319
Apple
AAPL
$4.95T
-279,200
Closed -$10.8M
ACTG icon
320
Acacia Research
ACTG
$447M
-21,000
Closed -$96K
AEO icon
321
CALL
American Eagle Outfitters
AEO
$2.98B
-75,000
Closed -$1.07M
AEO icon
322
American Eagle Outfitters
AEO
$2.98B
-435,300
Closed -$6.22M
AMAT icon
323
Applied Materials
AMAT
$410B
-12,500
Closed -$651K
AMD icon
324
Advanced Micro Devices
AMD
$807B
-56,800
Closed -$724K
AMZN icon
325
CALL
Amazon
AMZN
$2.49T
-390,000
Closed -$18.7M

Similar funds

J. Goldman & Co's Q4 2017 Portfolio in Review

As of Q4 2017, J. Goldman & Co held 502 positions worth $1.91B, down 3.9% from $1.98B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

J. Goldman & Co withdrew a net $132M in Q4 2017, closing 186 positions and reducing 71 holdings. Its most notable exit was B&G Foods, an estimated $27.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 7.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, J. Goldman & Co opened a new position in Knight Transportation worth $24.9M.

  • J. Goldman & Co's largest Q4 2017 buy was Knight Transportation: 569,183 shares worth $24.9M.
  • J. Goldman & Co added most to Dell in Q4 2017, an estimated $58.2M increase.
  • J. Goldman & Co's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $29.1M.
  • J. Goldman & Co fully exited B&G Foods in Q4 2017, selling an estimated $27.4M.
  • J. Goldman & Co's ten largest holdings make up 22% of its $1.91B portfolio in Q4 2017.
  • J. Goldman & Co opened 175 new positions and closed 186 in Q4 2017.
  • J. Goldman & Co's portfolio value fell 3.9% quarter-over-quarter to $1.91B.

Based on J. Goldman & Co's 13F filing for Q4 2017, filed 14 Feb 2018.